Labiotech May 27, 2026 The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Labiotech May 25, 2026 Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
Labiotech May 22, 2026 The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Labiotech May 19, 2026 Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows
Labiotech May 15, 2026 Freeze variability, not progress: strengthen your cell therapy supply chain from the start